Deliver patient-centric solutions
Improving the lives of future generations calls for visionary thinkers, brave leadership, and bold actions. At Manyone, we partner with leading pharmaceutical companies to deliver better outcomes and lasting impact.
Bringing a human-first approach to systemic health transformation
We partner with top-tier pharma brands to co-create everything that’s next for patients, healthcare professionals (HCPs), and businesses.
With experience spanning hundreds of projects, we have a strong track record of collaborating with global pharma and life science brands across strategy, brand design, large-scale web portals, spatial design, Software as a Medical Device (SaMD) design, front-end development, creative technology, digital strategies, product branding, employer branding, and product marketing.
Featured clients
More than 300 projects across corporate and product brands, and internal and external experiences delivered to date
A brand narrative and refresh for one of the world’s leading biotech companies
Vision and design for the end-to-end patient experience for two of the company's treatment areas
Making the future vision and customer experience for an important business area tangible and desirable
Digital transformation in pharma
Navigating complexity and seizing tomorrow’s opportunities require a holistic approach—understanding the entire ecosystem to create lasting impact.
At Manyone, we bring cross-disciplinary strategic design expertise to accelerate digital transformation in the pharma sector. With a proven track record, we deliver end-to-end solutions that drive meaningful change.
Here are our core beliefs:
Embracing digital transformation is integral to success
Digital transformation is reshaping the entire value chain, making it essential for health companies to integrate digital solutions effectively. To succeed, pharma companies must navigate the intersection of therapeutics and technology while addressing regulatory challenges. Their ability to develop and sustain digital platforms that enhance compliance, improve treatment outcomes, and empower patients will be a key determinant of success.
Solutions should be designed with patients at the center
Improving health and outcomes have always been at the core of progress, but today’s patients take center stage – and control. The days where patients simply follow doctor’s orders are gone; today's patients want to understand medication, and how treatments work, in detail. When talking to the HCP, we are also talking to the patient by proxy. Contained and convoluted processes and ecosystems are becoming a thing of the past.
Behavioral segmentation enables tailored, impactful user experiences
Behavioral segmentation involves categorizing users based on their actions, preferences, and motivations – enabling companies to create more personalized and effective solutions. In the pharmaceutical industry, this approach enhances product development and tailors patient communication, leading to improved treatment experiences and outcomes.
Traditional segmentation methods often overlook the nuances of patient behavior, and can result in generalized solutions that may not address specific needs. By focusing on actual user behavior, pharma companies can design more relevant and impactful interventions, fostering better engagement and satisfaction among patients.
Branding is an imperative to sustainable growth
In a competitive market, a brand is far more than aesthetics – it's a strategic asset that can shape your organization's identity and fuel long-term growth.
Countless digital health services, some with disruptive powers, are entering the market. Their strong brands and the consumer lock-in they obtain will define the health and pharmaceutical market of tomorrow, just as we saw when fintech services entered the financial market years ago.
Brands are entering the spotlight, facing a rising demand by consumers for accountability and transparency. People expect the brands they engage in to stand for something. It’s time to step into the limelight and have a voice.
Behavioral segmentation focuses on motivations and actions, enabling tailored, impactful user experiences.
Insight
How behavioral segmentation is driving pharma's digital evolution
Digital health is transforming the pharmaceutical industry. While many organizations invest heavily in digital solutions, senior leadership tends to overlook a fundamental component of their success – understanding their users' behaviors, motivations, and needs. Behavioral segmentation is a crucial tool to bridge this gap.
Want to know more?
Are you curious to learn more about our work in pharma, or do you want to explore our case studies? Don’t hesitate to reach out – we’d love to discuss how we can help you design for the future.
Client results
Novo Nordisk
Transforming a global brand
- Branding
- Healthcare
Perosphere Technologies
Transforming a medical device into a market-ready brand
- Branding
- Healthcare
BrainQ
A giant leap in neural recovery
- Industrial design
- Engineering
- Healthcare
Oticon
Using virtual reality to bring sound technology to life
- AR and VR
- Healthcare
Biologix
Democratizing healthcare through at-home sleep apnea tests
- Industrial design
- Digital product development
- Healthcare
Norwegian Directorate of Health
Tackling the escalating misuse of prescription drugs
- Strategic foresight
- Service design
- Transformation
- Healthcare
Looking for inspiration?
Behavioral segmentation in pharma
As digital health evolves, companies adopting behavioral segmentation will lead innovation and redefine patient engagement – delivering better outcomes and lasting impact.
- Customer experience (CX)
- Business innovation
- Healthcare
